ALPHA TAU MEDICAL LTD (DRTS) Stock Price & Overview

NASDAQ:DRTS • IL0011839383

Current stock price

7.25 USD
+0.08 (+1.12%)
At close:
7.25 USD
0 (0%)
After Hours:

The current stock price of DRTS is 7.25 USD. Today DRTS is up by 1.12%. In the past month the price increased by 0.55%. In the past year, price increased by 177.78%.

DRTS Key Statistics

52-Week Range2.3 - 8.6
Current DRTS stock price positioned within its 52-week range.
1-Month Range6.1 - 8.6
Current DRTS stock price positioned within its 1-month range.
Market Cap
638.073M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.47
Dividend Yield
N/A

DRTS Stock Performance

Today
+1.12%
1 Week
+8.05%
1 Month
+0.55%
3 Months
+43.00%
Longer-term
6 Months +77.26%
1 Year +177.78%
2 Years +145.76%
3 Years +152.61%
5 Years N/A
10 Years N/A

DRTS Stock Chart

ALPHA TAU MEDICAL LTD / DRTS Daily stock chart

DRTS Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to DRTS. When comparing the yearly performance of all stocks, DRTS is one of the better performing stocks in the market, outperforming 97.52% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

DRTS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to DRTS. DRTS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

DRTS Earnings

Next Earnings DateN/A
Last Earnings DateMar 9, 2026
PeriodQ4 / 2025
EPS Reported-$0.08
Revenue Reported
EPS Surprise 36.49%
Revenue Surprise %

DRTS Forecast & Estimates

10 analysts have analysed DRTS and the average price target is 8.41 USD. This implies a price increase of 16.07% is expected in the next year compared to the current price of 7.25.


Analysts
Analysts86
Price Target8.41 (16%)
EPS Next Y-4.28%
Revenue Next YearN/A

DRTS Groups

Sector & Classification

Index Membership

DRTS Financial Highlights

Over the last trailing twelve months DRTS reported a non-GAAP Earnings per Share(EPS) of -0.47. The EPS decreased by -4.44% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-42.63M
Industry RankSector Rank
PM (TTM) N/A
ROA -40.35%
ROE -55.29%
Debt/Equity 0.08
Chartmill High Growth Momentum
EPS Q2Q%38.46%
Sales Q2Q%N/A
EPS 1Y (TTM)-4.44%
Revenue 1Y (TTM)N/A

DRTS Ownership

Ownership
Inst Owners3.37%
Shares88.01M
Float60.12M
Ins Owners16.16%
Short Float %1.04%
Short Ratio1.55

DRTS Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.14191.058B
ISRG INTUITIVE SURGICAL INC47.3171.691B
SYK STRYKER CORP23.11133.773B
BSX BOSTON SCIENTIFIC CORP19.96103.561B
EW EDWARDS LIFESCIENCES CORP27.7348.532B
IDXX IDEXX LABORATORIES INC39.5646.687B
BDX BECTON DICKINSON AND CO11.7645.635B
RMD RESMED INC18.7833.595B
GEHC GE HEALTHCARE TECHNOLOGY13.9632.892B
DXCM DEXCOM INC26.0925.532B
ZBH ZIMMER BIOMET HOLDINGS INC1118.254B
HOLX HOLOGIC INC15.3116.777B
PODD INSULET CORP34.7515.816B

About DRTS

Company Profile

DRTS logo image Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.

Company Info

IPO: 2022-03-08

ALPHA TAU MEDICAL LTD

Kiryat Hamada 5

JERUSALEM IL

Employees: 125

DRTS Company Website

DRTS Investor Relations

Phone: 97235774115

ALPHA TAU MEDICAL LTD / DRTS FAQ

What does DRTS do?

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.


What is the current price of DRTS stock?

The current stock price of DRTS is 7.25 USD. The price increased by 1.12% in the last trading session.


Does DRTS stock pay dividends?

DRTS does not pay a dividend.


What is the ChartMill rating of ALPHA TAU MEDICAL LTD stock?

DRTS has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is ALPHA TAU MEDICAL LTD worth?

ALPHA TAU MEDICAL LTD (DRTS) has a market capitalization of 638.07M USD. This makes DRTS a Small Cap stock.